PB Ratio: 2.35

Basis: FMP quote market capitalization / matching reported stockholders equity. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/B ratio high or low?

The P/B ratio of 2.35 is 20% below its estimated 5-year average of 2.93, near the low end of its estimated 5-year range (1.24–11.23).

As of 2026-10-02T19:40:13.826Z. 11.03% below its estimated 12-month average of 2.64.

BEAM PB Ratio Metrics

P/B vs. estimated history

At 2.35, P/B is below its estimated 7-year median — higher than 20% of readings in its estimated 7-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Book Value Analysis

PB Ratio Formula & Definition

PB Ratio = Market Cap / Total Shareholders' Equity

The price-to-book ratio compares market capitalization to book value (shareholders' equity). Lower values can indicate a cheaper valuation relative to net assets.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PB Ratio FAQ

What is the P/B ratio for Beam Therapeutics Inc. (BEAM)?

The P/B ratio for BEAM stock is 2.35.

Is Beam Therapeutics Inc.'s P/B ratio high or low?

The P/B ratio of 2.35 is 20% below its estimated 5-year average of 2.93, near the low end of its estimated 5-year range (1.24–11.23).

What is the estimated TTM average P/B ratio for Beam Therapeutics Inc. (BEAM)?

The estimated TTM average P/B ratio for BEAM stock is 2.64.

What is the estimated 3Y average P/B ratio for Beam Therapeutics Inc. (BEAM)?

The estimated 3Y average P/B ratio for BEAM stock is 2.44.

What is the estimated 5Y average P/B ratio for Beam Therapeutics Inc. (BEAM)?

The estimated 5Y average P/B ratio for BEAM stock is 2.93.

Showing the most recent 260 of 1,672 data points. The chart above shows the full history.

Related Metrics